BEAM THERAPEUTICS INC shareholders Q4 2022

BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 211 filers reported holding BEAM THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 2.00 and the average weighting 0.3%.

BEAM THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
MWG Management Ltd. 2,346,934$91,788,58946.86%
HSG Holding Ltd 796,089$31,135,0413.16%
Redmile Group, LLC 1,770,587$69,247,6582.83%
ARK Investment Management 8,213,131$321,215,5532.78%
Deep Track Capital, LP 1,166,473$45,620,7591.92%
Tri Locum Partners LP 82,018$3,208,0001.30%
Casdin Capital, LLC 370,000$14,470,7001.12%
BRANDYWINE MANAGERS, LLC 8,067$315,5001.10%
Yiheng Capital Management, L.P. 463,800$18,139,2180.80%
FARALLON CAPITAL MANAGEMENT LLC 3,399,921$132,970,9100.79%
Alphabet Inc. 321,604$12,577,9320.73%
Renaissance Capital LLC 23,223$908,2520.71%
Temasek Holdings (Private) Ltd 2,878,297$112,570,1960.66%
TANG CAPITAL MANAGEMENT LLC 95,000$3,715,4500.54%
SECTORAL ASSET MANAGEMENT INC 63,500$2,483,4850.48%
Capital Impact Advisors, LLC 12,155$475,3820.46%
Nikko Asset Management Americas, Inc. 673,690$26,348,0160.38%
Bellevue Group AG 696,721$27,248,7580.36%
Green Alpha Advisors, LLC 10,290$402,0000.33%
Hood River Capital Management LLC 231,397$9,049,9370.33%
External links

This page lists BEAM THERAPEUTICS INC's shareholders in Q4 2022. To view BEAM THERAPEUTICS INC's shareholder history, click here.